STRUCTURE OF ADVANCED MAILLARD REACTION-PRODUCTS AND THEIR PATHOLOGICAL ROLE

Citation
Vm. Monnier et al., STRUCTURE OF ADVANCED MAILLARD REACTION-PRODUCTS AND THEIR PATHOLOGICAL ROLE, Nephrology, dialysis, transplantation, 11, 1996, pp. 20-26
Citations number
30
Categorie Soggetti
Urology & Nephrology",Transplantation
ISSN journal
09310509
Volume
11
Year of publication
1996
Supplement
5
Pages
20 - 26
Database
ISI
SICI code
0931-0509(1996)11:<20:SOAMRA>2.0.ZU;2-E
Abstract
In this article we review recent progress and controversies relating t o three areas of the field of advanced glycosylation end-products (AGE ). A controversy exists as to whether pyrraline, an AGE detectable by immunohistochemistry in kidneys from patients with renal failure, exis ts in vivo. Recent data from the authors' laboratory revealed that pyr raline is present in alkaline or protease digests from human skin and plasma. However, the amounts are very low and pyrraline was found to u ndergo further reactions to form an ether with itself (dipyrraline) as well as a thioether with cysteine. This high reactivity of pyrraline may explain the difficulty of quantitating it accurately in biological material. In contrast, the glycoxidation products carboxymethyllysine (CML) and pentosidine are stable, very resistant to acid hydrolysis a nd easy to quantitate. They are present in elevated concentrations in the extracellular matrix in diabetes mellitus and ageing. In the diabe tic human lens, CML is not elevated, in contrast to pentosidine, sugge sting a different mechanism of formation. Recent data in diabetic dogs have shown that pentosidine is elevated only in lenses from poorly co ntrolled dogs, in contrast to LM-1, a fluorophore thought to arise fro m ascorbate. Further studies are needed to clarify the intracellular m echanism of glycoxidation. The greatest concentrations of AGEs and gly coxidation products are found in patients with end-stage renal disease , and they are almost completely normalized by renal transplantation. Comparison of peritoneal dialysis (PD) with haemodialysis (HD) showed that PD is associated with lower plasma protein pentosidine, possibly due to selective transport of pentosidine-rich protein across the peri toneal wall. Fractionation of plasma proteins from ESRD patients by si ze showed that 90% of pentosidine is linked to HMW protein and 1-2% is in free form. The mechanism of accelerated glycoxidation in ESRD is s till not understood.